Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke
A randomized controlled study was conducted on the application of smart wearable devices in the intervention of high-risk populations for stroke, with a focus on whether the functions of smart wearable devices such as medication reminders, heart rate monitoring, and exercise reminders can effectively benefit the improvement of key risk factors for stroke, especially blood pressure, blood glucose, and blood lipids.
Age
30 - No limit years
Sex
ALL
Healthy Volunteers
No
Affiliated Hospital of Nantong University
Nantong, Jiangsu, China
Start Date
April 20, 2025
Primary Completion Date
October 20, 2025
Completion Date
April 20, 2026
Last Updated
April 30, 2025
300
ESTIMATED participants
Wearable Devices
BEHAVIORAL
Lead Sponsor
Affiliated Hospital of Nantong University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT00001987